Menu
2022 Session

Budget Amendments - SB30 (Member Request)

View Budget Item
View Budget Item amendments

Chief Patron: Boysko
Co-Patron(s): Barker, Boysko, Deeds, Ebbin, Edwards, Favola, Hashmi, Howell, Lewis, Locke, Lucas, Marsden, Mason, McClellan, Morrissey, Petersen, Saslaw, Spruill, Surovell
SB 441: Essential Personal Hygiene Products Tax Exemption (language only) (language only)

Item 0 #4s

Item 0 #4s

Revenues
Revenues

Language

Page 1, strike lines 19-38 and insert:

                                                                                                                            

                                                                                                                                                                                                                                                

"First Year

Second Year

Total

Unreserved Beginning Balance

$4,166,900,940

$0

$4,166,900,940

Additions to Balance

$1,440,246,365

($500,000)

$1,439,746,365

Official Revenue Estimates

$25,782,944,000

$28,073,024,800

$53,855,968,800

Transfer

$726,420,991

$744,020,991

$1,470,441,982

Total General Fund Resources Available for Appropriation

$32,116,512,296

$28,816,545,791

$60,933,058,087

First Year

Second Year

Total

Balance, June 30, 2022

$8,383,240,878

$0

$8,383,240,878

Official Revenue Estimates

$43,792,440,088

$44,616,962,722

$88,409,402,810

Lottery Proceeds Fund

$764,671,715

$764,671,715

$1,529,343,430

Internal Service Fund

$2,797,332,311

$2,750,473,321

$5,547,805,632

Bond Proceeds

$157,296,000

$0

$157,296,000

Total Nongeneral Fund Revenues Available for Appropriation  

$55,894,980,992

$48,132,107,758

$104,027,088,750

Total Projected Revenue

$88,011,493,288

$76,948,653,549

$164,960,146,837"



Explanation

(This amendment reflects the general fund revenue reduction from the creation of a sales and use tax exemption for essential personal hygiene items defined to include both menstrual supplies and incontinence products. The enactment of SB 441 is estimated to reduce general fund revenues by $4.7 million in FY 2023 and $5.3 million in FY 2024. The introduced budget accounts for a revenue reduction from the general fund of $872,000 per year to exempt menstrual supplies from the retail sales and use tax. The inclusion of essential personal hygiene nondurable incontinence products would result in a further general fund revenue reduction of $3.8 million in FY 2023 and $4.4 million in FY 2024.)